Aging in individuals with the FMR1 mutation
- PMID: 15000674
- PMCID: PMC3249442
- DOI: 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2
Aging in individuals with the FMR1 mutation
Abstract
Individuals with fragile X mental retardation 1 (FMR1) premutation (55 to 200 CGG repeats) are typically unaffected by fragile X syndrome. However, a subgroup of older males with the premutation have developed a neurological syndrome, which usually begins between 50 and 70 years and is associated with a progressive intention tremor and/or ataxia manifested by balance problems, frequent falling, and Parkinsonian symptoms, such as masked facies, intermittent resting tremor, and mild rigidity. This finding has been termed the fragile X-associated tremor/ataxia syndrome (FXTAS) and has brought focus to the aging process in individuals with the FMR1 mutation. The premutation is associated with elevated messenger RNA levels leading to the formation of intranuclear inclusions in neurons and astrocytes associated with FXTAS. This review is a summary of our experience with FXTAS in male carriers of the premutation.
Figures
Similar articles
-
Fragile X-associated tremor/ataxia syndrome (FXTAS).Ment Retard Dev Disabil Res Rev. 2004;10(1):25-30. doi: 10.1002/mrdd.20005. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994285 Review.
-
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.JAMA. 2004 Jan 28;291(4):460-9. doi: 10.1001/jama.291.4.460. JAMA. 2004. PMID: 14747503
-
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).Brain. 2006 Jan;129(Pt 1):243-55. doi: 10.1093/brain/awh683. Epub 2005 Dec 5. Brain. 2006. PMID: 16332642
-
A cerebellar tremor/ataxia syndrome among fragile X premutation carriers.Cytogenet Genome Res. 2003;100(1-4):206-12. doi: 10.1159/000072856. Cytogenet Genome Res. 2003. PMID: 14526182 Review.
-
[Neurodevelopmental (fragile X syndrome) and neurodegenerative (tremor/ataxia syndrome) disorders associated to the 'growth' of a gene].Rev Neurol. 2005 Apr 1-15;40(7):431-7. Rev Neurol. 2005. PMID: 15849678 Review. Spanish.
Cited by
-
Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review.J Geriatr Psychiatry Neurol. 2023 Nov;36(6):435-460. doi: 10.1177/08919887231164357. Epub 2023 Mar 20. J Geriatr Psychiatry Neurol. 2023. PMID: 36941085 Free PMC article. Review.
-
Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes.Sci Rep. 2022 Dec 10;12(1):21382. doi: 10.1038/s41598-022-25615-2. Sci Rep. 2022. PMID: 36496525 Free PMC article.
-
Allopregnanolone Improves Locomotor Activity and Arousal in the Aged CGG Knock-in Mouse Model of Fragile X-Associated Tremor/Ataxia Syndrome.Front Neurosci. 2021 Dec 3;15:752973. doi: 10.3389/fnins.2021.752973. eCollection 2021. Front Neurosci. 2021. PMID: 34924931 Free PMC article.
-
Molecular Pathogenesis and Peripheral Monitoring of Adult Fragile X-Associated Syndromes.Int J Mol Sci. 2021 Aug 4;22(16):8368. doi: 10.3390/ijms22168368. Int J Mol Sci. 2021. PMID: 34445074 Free PMC article. Review.
-
Functional motor control deficits in older FMR1 premutation carriers.Exp Brain Res. 2019 Sep;237(9):2269-2278. doi: 10.1007/s00221-019-05566-3. Epub 2019 Jun 3. Exp Brain Res. 2019. PMID: 31161414 Free PMC article.
References
-
- Aziz ME, Stathopulu M, Callias C, Taylor J, Turk B, Oostra B, Willemsen R, Patton M. Clinical features of boys with fragile X premutations & intermediate alleles. American Journal of Medical Genetics. 2003;121B(1):119–127. - PubMed
-
- Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P, Goetz CG. Tremor and ataxia in fragile X pre-mutation carriers: Blinded videotape study. Annals of Neurology. 2003;53(5):616–623. - PubMed
-
- Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis E, Grigsby J, Leehey M, Tassone F, Brown WT, Greco C, Hagerman PJ. Fragile X premutation carriers: Characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. American Journal of Neuroradiology. 2002;23:1757–1766. - PMC - PubMed
-
- Chen M, Ova VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Medicine. 2000;6(7):797–801. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical